CAS: 1058137-23-7 - Lucitanib
Fórmula:C26H25N3O4
InChI:InChI=1S/C26H25N3O4/c1-28-25(30)19-5-3-4-16-12-17(6-7-18(16)19)33-22-8-11-29-21-14-24(23(31-2)13-20(21)22)32-15-26(27)9-10-26/h3-8,11-14H,9-10,15,27H2,1-2H3,(H,28,30)
Clave InChI:InChIKey=CUDVHEFYRIWYQD-UHFFFAOYSA-N
SMILES:O=C(NC)C1=CC=CC2=CC(OC=3C=CN=C4C=C(OCC5(N)CC5)C(OC)=CC43)=CC=C21
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Lucitanib REF: TM-T15185CAS: 1058137-23-7 | 98% | 47,00 €~694,00 € | Vie 03 May 24 |
 | E-3810 REF: AN-AG008TFOCAS: 1058137-23-7 | 98% | A consultar | Vie 03 May 24 |
 | Lucitanib REF: 3D-ISB13723CAS: 1058137-23-7 | Min. 95% | A consultar | Vie 14 Jun 24 |
Lucitanib
CAS:1058137-23-7
Lucitanib (E-3810) is a novel VEGFR and FGFR inhibitor. It potently and selectively inhibits VEGFR1, …
Fórmula:
C26H25N3O4
Pureza:
98%
Forma y color:
Solid
Peso molecular:
443.49
Ref: TM-T15185
| 1mg | 47,00 € | |
| 2mg | 62,00 € | |
| 5mg | 96,00 € | |
| 10mg | 142,00 € | |
| 25mg | 265,00 € | |
| 50mg | 479,00 € | |
| 100mg | 694,00 € | |
| 1ml*10 (DMSO) | 94,00 € |
Entrega estimada en Estados Unidos, el Viernes 3 de Mayo de 2024
Ref: AN-AG008TFO
| 1mg | 134,00 € | |
| 5mg | 247,00 € | |
| 10mg | 536,00 € | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 3 de Mayo de 2024
Lucitanib
CAS:1058137-23-7
Lucitanib is a potent anti-tumor agent that inhibits the growth of cancer cells by inhibiting …
Fórmula:
C26H25N3O4
Pureza:
Min. 95%
Peso molecular:
443.49 g/mol
Ref: 3D-ISB13723
| 1mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 14 de Junio de 2024
